HR 6568 110th Congress House Health Clinical trials Congress Congressional investigations Congressional reporting requirements Economics and Public Finance Education Federal aid to research Government Operations and Politics Government publicity Health education Higher education Hypertension Lung diseases Medicaid Medical education Medical research Medicare Public service advertising Research grants

Tom Lantos Pulmonary Hypertension Research and Education Act of 2008

Introduced: July 22, 2008 See on congress.gov

Everywhere this bill has been 11 steps

Introduced

In committee

Reported out

Passed House

Passed Senate

To President

Became law

Sep 26, 2008

Received in the Senate.

Sep 25, 2008

Motion to reconsider laid on the table Agreed to without objection.

Sep 25, 2008

On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H9914)

Sep 25, 2008

Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.(text: CR H9914)

Sep 25, 2008

DEBATE - The House proceeded with forty minutes of debate on H.R. 6568.

Sep 25, 2008

Considered under suspension of the rules. (consideration: CR H9914-9916)

Sep 25, 2008

Mr. Pallone moved to suspend the rules and pass the bill, as amended.

Sep 23, 2008

Ordered to be Reported by Voice Vote.

Sep 23, 2008

Committee Consideration and Mark-up Session Held.

Jul 22, 2008

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Jul 22, 2008

Introduced in House

Plain-English summary Congressional Research Service

Tom Lantos Pulmonary Hypertension Research and Education Act of 2008 - Title I: Research on Pulmonary Hypertension - (Sec. 101) Expresses the sense of the Congress that: (1) the Secretary of Health and Human Services, acting through the Director of the National Institutes of Health (NIH) and the Director of the National Heart, Lung, and Blood Institute, should continue aggressive work on pulmonary hypertension; and (2) the Director of the Institute should continue research to expand the understanding of the causes of, and to find a cure for, pulmonary hypertension.

Requires inclusion of information on the status of pulmonary hypertension research at NIH in biennial reports to Congress.

Title II: Increasing Awareness of Pulmonary Hypertension - (Sec. 201) Requires the Secretary, acting through the Director of the Centers for Disease Control and Prevention (CDC), to carry out an educational campaign to increase public awareness of pulmonary hypertension, which may include information on: (1) pulmonary hypertension and its symptoms; (2) the incidence and prevalence of pulmonary hypertension; (3) diseases and conditions that can lead to pulmonary hypertension as a secondary diagnosis; (4) the importance of early diagnosis; and (5) the availability of a range of treatment options.

(Sec. 202) Requires the Secretary, acting through the Administrator of the Health Resources and Services Administration (HRSA) and the Director of CDC, to carry out an educational campaign to increase awareness of pulmonary hypertension among health care providers, which may include information on: (1) the symptoms of pulmonary hypertension; (2) the importance of early diagnosis; (3) current diagnostic criteria; and (4) Food and Drug Administration-approved therapies for the disease. Requires such campaign to target health care providers, including cardiologists, pulmonologists, rheumatologists, primary care physicians, pediatricians, and nurse practitioners.

Sets forth reporting requirements.

Authorizes appropriations for FY2009-FY2011.

What's happening now September 26, 2008

Received in the Senate.

Committees of jurisdiction 2